前往化源商城

The Veterinary Journal 2015-09-01

AICAR administration affects glucose metabolism by upregulating the novel glucose transporter, GLUT8, in equine skeletal muscle.

M A de Laat, M A Robinson, K J Gruntmeir, Y Liu, L R Soma, V A Lacombe

文献索引:Vet. J. 205 , 381-6, (2015)

全文:HTML全文

摘要

Equine metabolic syndrome is characterized by obesity and insulin resistance (IR). Currently, there is no effective pharmacological treatment for this insidious disease. Glucose uptake is mediated by a family of glucose transporters (GLUT), and is regulated by insulin-dependent and -independent pathways, including 5-AMP-activated protein kinase (AMPK). Importantly, the activation of AMPK, by 5-aminoimidazole-4-carboxamide-1-D-ribofuranoside (AICAR) stimulates glucose uptake in both healthy and diabetic humans. However, whether AICAR promotes glucose uptake in horses has not been established. It is hypothesized that AICAR administration would enhance glucose transport in equine skeletal muscle through AMPK activation. In this study, the effect of an intravenous AICAR infusion on blood glucose and insulin concentrations, as well as on GLUT expression and AMPK activation in equine skeletal muscle (quantified by Western blotting) was examined. Upon administration, plasma AICAR rapidly reached peak concentration. Treatment with AICAR resulted in a decrease (P <0.05) in blood glucose and an increase (P <0.05) in insulin concentration without a change in lactate concentration. The ratio of phosphorylated to total AMPK was increased (P <0.05) in skeletal muscle. While GLUT4 and GLUT1 protein expression remained unchanged, GLUT8 was increased (P <0.05) following AICAR treatment. Up-regulation of GLUT8 protein expression by AICAR suggests that this novel GLUT isoform plays an important role in equine muscle glucose transport. In addition, the data suggest that AMPK activation enhances pancreatic insulin secretion. Collectively, the findings suggest that AICAR acutely promotes muscle glucose uptake in healthy horses and thus its therapeutic potential for managing IR requires investigation. Copyright © 2015 Elsevier Ltd. All rights reserved.

相关化合物

结构式 名称/CAS号 全部文献
十二烷基硫酸钠 结构式 十二烷基硫酸钠
CAS:151-21-3
1H-咪唑-4-甲酸 结构式 1H-咪唑-4-甲酸
CAS:1072-84-0
阿卡地辛 结构式 阿卡地辛
CAS:2627-69-2
β-烟酰胺腺嘌呤二核苷酸磷酸钠盐 结构式 β-烟酰胺腺嘌呤二核苷酸磷酸钠盐
CAS:1184-16-3